Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.

Literature DB >> 14516890

Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.

Svein Solheim¹, Harald Arnesen, Lars Eikvar, Mette Hurlen, Ingebjørg Seljeflot.

Abstract

The aim of this study was to assess the influence of aspirin on selected inflammatory markers in patients recovering from acute myocardial infarction (AMI). Patients participating in the Warfarin Aspirin Re-Infarction Study-II were randomized to either aspirin 160 mg/day or aspirin 75 mg/day + warfarin, or warfarin alone after AMI. After AMI, aspirin 160 mg/day was associated with significantly lower levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha than warfarin alone over 4 years. However, the same levels were not predictors for clinical end points.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2003 PMID： 14516890 DOI： 10.1016/s0002-9149(03)00897-x

Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778

Keyword Cloud
Cited

13 in total

1. Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome.

Authors: Ian M Kronish; Nina Rieckmann; Daichi Shimbo; Matthew Burg; Karina W Davidson
Journal: Am J Cardiol Date: 2010-10-15 Impact factor: 2.778

2. Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors: Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal: Brain Behav Immun Date: 2018-06-19 Impact factor: 7.217

3. Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis.

Authors: V Mitrovic; H H Klein; N Krekel; J Kreuzer; S Fichtlscherer; A Schirmer; W D Paar; C W Hamm
Journal: Z Kardiol Date: 2005-05

4. Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial.

Authors: Lauren M Hurwitz; Ibrahim Kulac; Berrak Gumuskaya; Javier A Baena Del Valle; Ines Benedetti; Fan Pan; Jun O Liu; Michael T Marrone; Kathryn B Arnold; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ian M Thompson; Charles G Drake; William B Isaacs; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal: Cancer Prev Res (Phila) Date: 2020-06-24

5. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors: Krystle A Lang Kuhs; Allan Hildesheim; Britton Trabert; Troy J Kemp; Mark P Purdue; Nicolas Wentzensen; Hormuzd A Katki; Ligia A Pinto; Erikka Loftfield; Mahboobeh Safaeian; Anil K Chaturvedi; Meredith S Shiels
Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-02-23 Impact factor: 4.254

6. An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration.

Authors: Matt Fisher; Mary Cushman; Volker Knappertz; George Howard
Journal: Am Heart J Date: 2008-03-06 Impact factor: 4.749

7. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors: Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal: Brain Behav Immun Date: 2009-04-21 Impact factor: 7.217